Head of R&D & Quality Manager

• Leads the strategic direction, execution, and delivery of R&D programmes focused on molecular diagnostics, biosensor development, and rapid diagnostic solutions.
• Drives biosensor development targeting antimicrobial resistance (AMR), rapid diagnostics for emerging pandemic-potential pathogens, and sexually transmitted diseases (STDs).
• Leads rapid diagnostic development programmes for high-risk and emerging pathogens, supporting pandemic preparedness and global health security initiatives.
• Oversees end-to-end assay design, development, verification, validation, and clinical evaluation, translating research into deployable diagnostic products.
• Owns and continuously improves the company's Quality Management Systems (ISO 13485:2016, ISO 9001:2015, ISO 15189:2012), ensuring regulatory compliance and audit readiness.
• Leads internal audits, external assessments, supplier qualification, risk management, and CAPA; represents R&D and Quality at management reviews and regulatory discussions.

Scientist & Quality Manager – R&D

• Led assay development, optimisation, verification and validation for molecular diagnostic and biosensor-based platforms, designing R&D workflows, SOPs, and validation protocols.
• Built and managed laboratory operations, including staff recruitment, training, competency frameworks, equipment qualification, and supplier management.
• Played a central role in establishing and maintaining ISO 13485 and ISO 15189 compliant QMS, supporting regulatory submissions and audit readiness.
• Played a key technical role in developing, verifying, and clinically validating MPOX (Monkeypox) molecular diagnostic assays, contributing to a WHO Emergency Use Authorization (EUA) submission.

Molecular Diagnostic Scientist & Laboratory Manager

• Led end-to-end assay design, development, verification and validation for molecular diagnostic products, contributing directly to commercial product pipelines.
• Played a key technical role in validating fit-to-fly COVID-19 tests (LAMP and qPCR) at UK airports.
• Designed and implemented R&D workflows and SOPs; managed laboratory operations including staff training, equipment qualification, supplier management, and regulatory documentation.
• Key contributor to establishing and maintaining ISO 13485 and ISO 15189 compliant quality management systems, working closely with Quality & Regulatory Affairs on IVD submissions.

PhD in Biotechnology

Specialisation: Nanotechnology, Biosensors, Electrochemical Diagnostics, Glycation Biology

MSc in Molecular Medicine (Distinction)

MSc in Biotechnology

CGPA: 9.2/10

Gold Nanoparticle Based-Detection of Low Molecular Weight AGEs from In Vitro Glycated Hemoglobin A0 Samples

Synthesis of Graphenized Au/ZnO Plasmonic Nanocomposites for Simultaneous Sunlight-Mediated Photo-Catalysis and Anti-Microbial Activity

Growth Kinetics of Gold Nanoparticle Formation from Glycated Hemoglobin

Natural Occurrence of Carbon Dots during In Vitro Non-Enzymatic Glycosylation of Hemoglobin A0

Evaluation and Clinical Validation of Pan-Specific and Clade-Specific Diagnostic Real-Time PCR Assays for Monkeypox Virus

A Gold Nanoparticle-Based Colorimetric Biosensor for the Detection of Advanced Glycation End Products

A Low-Cost Point-of-Care Microfluidic Device for DNA/RNA Isolation, Purification and Amplification Using Chip-Based PCR/RT-PCR

6th NanoToday Conference